Lyophilized Injectable Drugs Market (Type of Packaging -Single-use Vials, Point-of-care Reconstitution, Specialty Packaging; Type of Delivery - Prefilled Diluent Syringes, Proprietary Reconstitution Devices, Single-step Devices, Multi-step Devices; Indication - Autoimmune Diseases, Infectious Diseases, Metabolic Conditions; End user - Hospitals, Ambulatory Surgical Centers, Specialty Clinics) - Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2021-2027

The global Lyophilized Injectable Drugs market gathered revenue around USD 6.1 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 7.1% during the prediction period 2021 to 2027.

Growth Factors:

Lyophilization refers to one of the most popular techniques employed today for the production of parenteral pharmaceutical products that do not maintain their stability in aqueous solution. The process is important for the protection of materials that need minimal moisture content (less than 1%) to achieve stability.

The popularity of lyophilized injectable drugs is increasing owing to their ability to remain stable at ambient temperatures. At the same time, they can be used following a simple rehydration process. As a result, this technique allows for avoiding various pipetting errors and helps in achieving streamlined and simplified workflows. On the back of all these advantages lyophilized injectable drugs, the global lyophilized injectable market is projected to gather lucrative avenues in the forthcoming years.

The global market is growing at a rapid pace due to rise in awareness and acceptance of lyophilized injectable drugs in proven applications and chronic medical conditions such as cardiac diseases and metabolic diseases. Increase in usage of lyophilized injectable drugs in combination therapy is anticipated to augment the global lyophilized injectable drugs market. 

The global lyophilized injectable drugs market has been segmented based on type of packaging, type of delivery, indication, and end-user. In terms of type of packaging, the market has been categorized into single-use vials, point-of-care reconstitution, specialty packaging, and others. Based on type of delivery, the global lyophilized injectable drugs market has been classified into prefilled diluent syringes, proprietary reconstitution devices, single-step devices, and multi-step devices. In terms of indication, the market has been divided into autoimmune diseases, infectious diseases, metabolic conditions, and others. Based on end-user, the market has been categorized into hospitals, ambulatory surgical centers, specialty clinics, and others. Moreover, lyophilized injectable drugs can be reconstituted easily and quickly, which is particularly valuable and useful for emergency antibiotics and vaccines that need to be administered quickly during causalities. Furthermore, lyophilized injectable drugs involve less cost compared to deep freezing and other conventional drug drying methods used for preservation of APIs and formulations. 

This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Lyophilized Injectable Drugs market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Lyophilized Injectable Drugs market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.

Report Coverage

Report Scope Details
Market Size USD 6.1 Billion by 2027
Growth Rate CAGR of 7.1% From 2021 to 2027
Base Year 2020
Forecast Period 2021 to 2027
Historic Data 2017 to 2020
Report coverage Growth Factors, Revenue Status, Competitive Landscape,  and Future Trends
Segments Covered Type of Packaging, Type of Delivery, By Indication, By End user and Region
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)
Companies Mentioned B. Braun Melsungen AG, Baxter, Becton, Dickinson and Company, Mylan N.V., Schott AG, SHL Group, Vetter Pharma, CIRON Drugs & Pharmaceuticals Pvt. Ltd, and Jubilant HollisterStier.

COVID-19 Impact Assessment on Market Landscape

The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.

Lyophilized Injectable Drugs market Report empowers readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.

Regional analysis:

North America was the leading market for lyophilized injectable drugs in 2020 primarily due to extensive research & development activities, rapid acceptance of innovative technologies, and significant investments toward the development of health care infrastructure. Additionally, presence of large number of manufacturing facilities in North America makes it the largest market for lyophilized injectable drugs. Moreover, large size of the contract manufacturing and services market in North America drives demand for lyophilized injectable drugs in the region. Asia Pacific presents significant opportunities in the health care sector, and was the third largest market in 2020. The region accounted for large share of the global lyophilized injectable drugs market in 2020. Asia Pacific comprises emerging economies such as India, China, Indonesia, Vietnam, the Philippines, Malaysia, Singapore, and Thailand. These countries present large opportunities in the health care sector. The lyophilized injectable drugs market is expected to grow at a rapid pace in the region in the next few years due to untapped opportunities, improving health care infrastructure, and increasing availability of contract manufacturing and research services.

Competitive Rivalry

Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.

Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.

  • Company Overview
  • Company Market Share/Positioning Analysis
  • Product Offerings
  • Financial Performance
  • Recent Initiatives
  • Key Strategies Adopted by Players
  • Vendor Landscape
  • List of Suppliers
  • List of Buyers

Some of the prominent players in the Lyophilized Injectable Drugs Market include:  B. Braun Melsungen AG, Baxter, Becton, Dickinson and Company, Mylan N.V., Schott AG, SHL Group, Vetter Pharma, CIRON Drugs & Pharmaceuticals Pvt. Ltd, and Jubilant HollisterStier. 

Segments Covered in the Report

This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for the period of 2017 to 2027 and covers subsequent region in its scope:

  • By Type of Packaging
  1. Single-use Vials
  2. Point-of-care Reconstitution
  3. Specialty Packaging
  • By Type of Delivery
  1.  Prefilled Diluent Syringes
  2.  Proprietary Reconstitution Devices
  3. Single-step Devices
  4. Multi-step Devices
  •  By Indication
  1.  Autoimmune Diseases
  2. Infectious Diseases
  3. Metabolic Conditions
  •  By End user
  1. Hospitals
  2. Ambulatory Surgical Centers
  3. Specialty Clinics

By Geography

North America

  • U.S.
  • Canada


  • Germany
  • France
  • United Kingdom
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Southeast Asia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Rest of Latin America

Middle East & Africa (MEA)

  • GCC
  • North Africa
  • South Africa
  • Rest of Middle East & Africa

Highlights of the Report:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the market.
  • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market
  • Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the market

Research Methodology

In the study, a unique research methodology is utilized to conduct extensive research on the growth of the Lyophilized Injectable Drugs market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the Lyophilized Injectable Drugs market study are as follows - statistics from government organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, all of whom have contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the market, and makes the projections on the growth prospects of the Lyophilized Injectable Drugs markets more accurate and reliable.

Secondary Research

It involves company databases such as Hoover's: This assists us recognize financial information, structure of the market participants and industry competitive landscape.

The secondary research sources referred in the process are as follows:

  • Governmental bodies, and organizations creating economic policies
  • National and international social welfare institutions
  • Company websites, financial reports and SEC filings, broker and investor reports
  • Related patent and regulatory databases
  • Statistical databases and market reports
  • Corporate Presentations, news, press release, and specification sheet of Manufacturers

Primary Research

Primary research includes face-to face interviews, online surveys, and telephonic interviews.

  • Means of primary research: Email interactions, telephonic discussions and Questionnaire based research etc.
  • In order to validate our research findings and analysis we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.

Industry participants involved in this research study include:

  • CEOs, VPs, market intelligence managers
  • Procuring and national sales managers technical personnel, distributors and resellers
  • Research analysts and key opinion leaders from various domains

Key Points Covered in Lyophilized Injectable Drugs Market Study:

  • Growth of Lyophilized Injectable Drugs in 2021
  • Market Estimates and Forecasts (2017-2027)
  •  Brand Share and Market Share Analysis
  •  Key Drivers and Restraints Shaping Market Growth
  •  Segment-wise, Country-wise, and Region-wise Analysis
  •  Competition Mapping and Benchmarking
  •  Recommendation on Key Winning Strategies
  •  COVID-19 Impact on Demand for Lyophilized Injectable Drugs and How to Navigate
  •  Key Product Innovations and Regulatory Climate
  •  Lyophilized Injectable Drugs Consumption Analysis
  •  Lyophilized Injectable Drugs Production Analysis
  •  Lyophilized Injectable Drugs and Management